Morten Hoyer
Morten Hoyer
Danish Center for Particle Therapy, Aarhus University Hospital
Verified email at
Cited by
Cited by
Outcome in a prospective phase II trial of medically inoperable stage I non–small-cell lung cancer patients treated with stereotactic body radiotherapy
P Baumann, J Nyman, M Hoyer, B Wennberg, G Gagliardi, I Lax, ...
Journal of Clinical Oncology 27 (20), 3290-3296, 2009
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
A Widmark, O Klepp, A Solberg, JE Damber, A Angelsen, P Fransson, ...
The Lancet 373 (9660), 301-308, 2009
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
A Widmark, A Gunnlaugsson, L Beckman, C Thellenberg-Karlsson, ...
The Lancet 394 (10196), 385-395, 2019
Phase II study on stereotactic body radiotherapy of colorectal metastases
M Hoyer, H Roed, A Traberg Hansen, L Ohlhuis, J Petersen, H Nellemann, ...
Acta oncologica 45 (7), 823-830, 2006
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Y Lievens, M Guckenberger, D Gomez, M Hoyer, P Iyengar, I Kindts, ...
Radiotherapy and Oncology 148, 157-166, 2020
Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
M Hoyer, H Roed, L Sengelov, A Traberg, L Ohlhuis, J Pedersen, ...
Radiotherapy and oncology 76 (1), 48-53, 2005
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma
TO Jensen, H Schmidt, HJ Moller, M Hoyer, MB Maniecki, P Sjoegren, ...
J Clin oncol 27 (20), 3330-3337, 2009
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
TO Jensen, H Schmidt, HJ M°ller, F Donskov, M H°yer, P Sjoegren, ...
Cancer 118 (9), 2476-2485, 2012
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer
M Guckenberger, N Andratschke, K Dieckmann, MS Hoogeman, M Hoyer, ...
Radiotherapy and Oncology 124 (1), 11-17, 2017
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
P Baumann, J Nyman, I Lax, S Friesland, M Hoyer, S Rehn Ericsson, ...
Acta oncologica 45 (7), 787-795, 2006
Radiotherapy for liver metastases: a review of evidence
M H°yer, A Swaminath, S Bydder, M Lock, AM Romero, B Kavanagh, ...
International Journal of Radiation Oncology* Biology* Physics 82 (3), 1047-1057, 2012
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review
SGC Kroeze, C Fritz, M Hoyer, SS Lo, U Ricardi, A Sahgal, R Stahel, ...
Cancer treatment reviews 53, 25-37, 2017
Stereotactic body radiotherapy for unresectable cholangiocarcinoma
N Kopek, MI Holt, AT Hansen, M H°yer
Radiotherapy and Oncology 94 (1), 47-52, 2010
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis
AC Begg, K Haustermans, AAM Hart, S Dische, M Saunders, B Zackrisson, ...
Radiotherapy and Oncology 50 (1), 13-23, 1999
Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation
O Hansen, J Overgaard, HS Hansen, M Overgaard, M H°yer, ...
Radiotherapy and oncology 43 (1), 47-51, 1997
The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas
M Nordsmark, M H°yer, J Keller, OS Nielsen, OM Jensen, J Overgaard
International Journal of Radiation Oncology* Biology* Physics 35 (4), 701-708, 1996
Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer
M Thor, JBB Petersen, L Bentzen, M H°yer, LP Muren
Acta Oncologica 50 (6), 918-925, 2011
Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer
L Fokdal, H HonorÚ, M H°yer, P Meldgaard, K Fode, H von der Maase
International Journal of Radiation Oncology* Biology* Physics 59 (2), 436-444, 2004
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer–a first report of toxicity related to COPD/CVD in a non-randomizedá…
P Baumann, J Nyman, M Hoyer, G Gagliardi, I Lax, B Wennberg, ...
Radiotherapy and Oncology 88 (3), 359-367, 2008
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
M Lambrecht, DBP Eekers, C Alapetite, NG Burnet, V Calugaru, ...
Radiotherapy and Oncology 128 (1), 26-36, 2018
The system can't perform the operation now. Try again later.
Articles 1–20